event-trade登录编辑
Seoul Economic Daily EnglishCodex · 实盘不做把握 7/10
北京时间·🕒 发布 10:59:59时区推断·⟳ 抓取 11:39:55·⚡ 决策 07-22 11:41:18 +1m23s·97.5 天前

Cosmax Pet投资约400亿韩元的新曾坪宠物健康ODM工厂投产

新工厂投产使Cosmax Pet生产空间扩大至原厂四倍以上,并新增宠物营养品、功能零食及粉末产线。

📄 原文Seoul Economic Daily English↗ 原文
Cosmax Pet Opens 40 Billion Won Jeungpyeong Plant, Quadrupling Capacity
Cosmax Pet, the pet health-and-beauty original design manufacturing (ODM) company of Cosmax Group, has begun full opera…
不做 Cosmax(192820.KS)
新厂投产方向偏利好,但未披露订单、客户、产能利用率或对上市公司收入利润的量级影响,400亿韩元投资额不是可交易收入增量,不做。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)

研究档案

🔎 新鲜度:最早出现 2026-07-22 · 扩散 low · price-in 风险 low ↗

关键理由

  • 新工厂投产使Cosmax Pet生产空间扩大至原厂四倍以上,并新增宠物营养品、功能零食及粉末产线。
  • 但事件主体为Cosmax集团旗下宠物ODM业务,报道未给出新增订单、客户锁定或投产后收入利润增量。
  • 400亿韩元为产能投资额,不等同于销售合同或利润增量,短线交易弹性不足。

主要风险

  • 若后续披露大客户ODM订单或产能利用率快速爬坡,可能重新具备事件交易价值。

原文全文

展开原文 · 2,719 字
Cosmax Pet, the pet health-and-beauty original design manufacturing (ODM) company of Cosmax Group, has begun full operation of its new plant in Jeungpyeong, North Chungcheong Province, strengthening its production capabilities. The company's strategy is to significantly expand production facilities and build new formulation production lines to respond to the growing pet healthcare market.
Cosmax Pet said on the 22nd that it has begun full operation of its new Jeungpyeong plant, relocating from its factory in Goesan, North Chungcheong Province. After signing an investment agreement with Jeungpyeong County last October, the company invested approximately 40 billion won to build the new production facility in the Jeungpyeong No. 2 General Industrial Complex.
The plant was established to respond to the rapidly growing pet health management market and increasing product development demand from clients. It specializes in producing pet nutritional supplements and functional treats, with production space more than four times larger than the existing Goesan plant. As a result, the company expects to respond more flexibly to demand for producing various products and customized development.
The production infrastructure has also been strengthened. In addition to existing capsule, pellet, tablet, and liquid-solid formulations, the company introduced new formulation production equipment for yokan-type products, squeeze gels, and liquid drops. It also built a powder production line with a manufacturing environment meeting human pharmaceutical Good Manufacturing Practice (GMP) standards, improving quality stability and production efficiency.
Through this, the company explained, it has become possible to develop various customized products tailored to pets' age, palatability, feeding convenience, and functional concepts. Cosmax Pet also plans to strengthen its ODM and OEM competitiveness, covering everything from product planning and ingredient proposals to formulation development, production, and quality control.
Cosmax Pet currently produces pet nutritional supplements and pet beauty products based on quality certification systems including ISO 9001 and ISO 22716. It is expanding development of functional products using more than 30 proprietary pet clinical ingredients, and has secured patented ingredients for pet cosmetics used in skin and coat care.
"The new Jeungpyeong plant is a specialized production hub for pet healthcare products," said Jin Ho-jeong, CEO of Cosmax Pet. "Based on our differentiated formulation development capabilities and proprietary ingredient competitiveness, we will actively respond to the diverse product development demands of domestic and overseas clients."

决策记录链 · 只追加

每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。

这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。